Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
Video of Martha Gulati explaining preventive cardiology advanacements for obese patients. #AHA24 #AHA2024 #CVprev

Martha Gulati highlights 'exciting' progress in preventive cardiology

Martha Gulati, MD, spoke to Cardiovascular Business at AHA Scientific Sessions 2024 about key developments in obesity treatment and CVD prevention.

Abbott FreeStyle Libre 3 CGM

Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment

Abbott expects the new facility to produce more FreeStyle Libre 3 sensors than anywhere else in the world.

doctor with overweight patient who may be treated with TAVR or surgery

Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years

The popular diabetes drug, which can also benefit patients with heart failure and sleep apnea, resulted in an average weight loss of 23%. Once treatment stopped, the effects started to fade rather quickly. 

artificial intelligence in cardiology

No-contact blood pressure and diabetes screening with AI shows promise

The new technology, still under development, could help physicians screen patients for diabetes and hypertension with high-speed video recordings. 

Video of FDA Commissioner Robert Califf, MD, explaining the need for clinicians to take up fight against health misinformation with grassroots efforts in their communities. #misinformation #FDA #science

FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Sanjit Jolly, MD, says cholchicine failed to help heart attack patients in the CLEAR SYNERGY (OASIS 9) presented as a TCT 2024 late-breaker.

Cardiologist explores why colchicine failed to help heart attack patients

Sanjit S. Jolly, MD, MSc, reviewed his team's late-breaking data on treating heart attack patients with colchicine. "I think inflammation is an important area, but I don't think colchicine is the magic bullet," he said.

Standing desks gained popularity in recent years, especially once the COVID-19 pandemic had more and more people working from home, but they may not necessarily make that much of a difference.

Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage

Sitting too long can be bad for the heart, but standing desks do not appear to make a difference.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

Abbott CGM sensors can now be worn during common imaging procedures

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

Displaying 9 - 16 of 962
Design by Adaptive Theme